Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Ars Technica
Moderna’s mRNA flu shot earns FDA approval after rollercoaster review
Read full article at Ars Technica
Disclaimer: This article summary is sourced from Ars Technica. HealthRankings provides this for informational purposes only. Always consult a qualified healthcare provider before making medical decisions.
More health news
Pittsburgh Post-Gazette
‘One piece of this puzzle’: Pitt-CMU collaboration makes novel discovery about Alzheimer’s disease
Yesterday
CBS News
Flesh-eating bacteria has killed 5 in Louisiana this year, officials say
Yesterday
Women's Health
Low Levels of This Vitamin Were Just Linked to Dementia. Are You Getting Enough?
Yesterday
Abcnews.com